[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352919-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352919-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","tissue-and-tumor-type-specific-expression-of-internal-promoter-driven-yeats-domain-devoid-isoforms-of-mllt1-and-mllt3","Tissue-and tumor-type-specific expression of internal-promoter-driven YEATS-domain-devoid isoforms of MLLT1 and MLLT3","","ENL and AF9 proteins, core components of the transcription super elongation complex, act as master regulators of gene expression and are encoded by MLLT1 and MLLT3, genes frequently altered in cancer. The study identifies internal promoters producing YEATS-domain-devoid AF9 and MLLT1 isoforms with distinct activity patterns across hematopoietic and digestive tissues. YEATS-domain-devoid MLLT1 shows tumor-type-specific biomarker behavior, including pituitary subtype enrichment and inverse association with EGFR mutation and favorable-prognosis signatures in non-small cell lung cancer.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/tissue-and-tumor-type-specific-expression-of-internal-promoter-driven-yeats-domain-devoid-isoforms-of-mllt1-and-mllt3/352919/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/tissue-and-tumor-type-specific-expression-of-internal-promoter-driven-yeats-domain-devoid-isoforms-of-mllt1-and-mllt3/352919.png","ImageObject",300,407,{"name":42,"@type":43},"Nguyễn Văn Học","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-19","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What roles do ENL and AF9 play in gene expression?","Question",{"text":63,"@type":64},"ENL and AF9 function as master regulators within the transcription super elongation complex and optimize transcriptional catalytic rates at specific genomic loci.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What do the internal promoters drive according to the study?",{"text":68,"@type":64},"Internal promoters drive expression of YEATS-domain-devoid isoforms from MLLT3 (AF9 isoform) and from the MLLT1 locus (MLLT1 isoform), with distinct tissue activity.",{"name":70,"@type":61,"acceptedAnswer":71},"How is YEATS-domain-devoid MLLT1 linked to cancer biomarkers?",{"text":72,"@type":64},"The YEATS-domain-devoid MLLT1 isoform shows tumor-type-specific biomarker values, with high expression in a gonadotroph pituitary tumor subtype and inverse correlation with EGFR mutation and a good-prognosis transcriptional signature in non-small cell lung cancer.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352919,1790197674,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},1374402739827,"https://ap-avatar.wpscdn.com/avatar/14000c97e7351f1a627?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787885694763230660","Dailhau etal. Biomarker Research (2026) 14:48 Biomarker Research  \n[https://doi.org/10.1186/s40364-026-00928-w](https://doi.org/10.1186/s40364-026-00928-w)  \nCORRESPONDENCE Open Access  \nTissue-and tumor-type-specific expression of internal-promoter-driven YEATS-domaindevoid isoforms of MLLT1 and MLLT3  \nSandra Dailhau 1, Ahmed Zamani1, Romain Pfeifer 1, Chloé Bessière1, Thérèse Commes2, Olivera Casar-Borota3,4, Christian Touriol1, Fabienne Meggetto1, Marina Bousquet 1, Nicolas Gilbert2* and Stéphane Pyronnet1*  \nAbstract  \nAs integral parts of the transcription super elongation complex, the ENL and AF9 proteins are two master regulators of gene expression involved in the development and homeostasis of various tissues. They are encoded by MLLT1 and MLLT3, two genes that frequently undergo oncogenic mutations or chromosomal translocations in cancers. In addition, we discovered an internal promoter driving the production of a YEATS (named after the five proteins first shown to contain this domain: Yaf9, ENL, AF9, Taf14, and Sas5)-domain-devoid AF9 isoform massively expressed in healthy hematopoietic stem cells (HSCs), as well as in the blasts of patients with extremely poorprognosis acute myeloid leukemia (AML) . Here, we show that such internal promoter is also active in a subset of digestive tissues, including the small intestine, colon and stomach. We also reveal the existence of a similar internal promoter in the MLLT1 locus that is inactive in the hematopoietic lineage and AML but functional in other healthy tissues, including the pituitary gland, brain, thyroid, uterus and lung. Furthermore, the YEATS-domaindevoid MLLT1 isoform may exhibit tumor-type-specific biomarker values, whereas full-length MLLT1 does not. It is highly expressed in the gonadotroph subtype of pituitary tumors, and its expression in non-small cell lung cancer inversely correlates with the epidermal growth factor mutation and a transcriptomic signature associated with a good prognosis. Thus, both MLLT1 and MLLT3 have tissue-and tumor-type-specific internal promoters driving expression of similar YEATS domain-devoid isoforms. This suggests that the functions of both MLLT1 and MLLT3 in tissue homeostasis and cancers, as well as their potentials as biomarkers should be re-evaluated taking into account expression of these YEATS-domain-devoid ENL and AF9 transcription factors.  \nKeywords MLLT1, MLLT3, ENL, AF9, Hematopoiesis, Acute myeloid leukemia, Pituitary tumor, Non-small cell lung cancer  \n*Correspondence:  \nNicolas Gilbert [nicolas.gilbert@inserm.fr](nicolas.gilbert@inserm.fr)[ ](nicolas.gilbert@inserm.fr)Stéphane Pyronnet [stephane.pyronnet@inserm.fr](stephane.pyronnet@inserm.fr)  \n1Univ Toulouse, CNRS, INSERM, CRCT (Cancer Research Center of Toulouse), UMR-1037, UMR-5071, Institut Universitaire du Cancer,  \nLaboratoire d’Excellence Toulouse Cancer (Labex TOUCAN),  \nToulouse 31037, France  \n2IRMB, Université de Montpellier, INSERM, Montpellier, France 3Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden  \n4Department of Clinical Pathology, Uppsala University Hospital, Uppsala, Sweden  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regu","cbCaiap81VpLfD2Q","https://ap.wps.com/l/cbCaiap81VpLfD2Q","pdf",1409667,"English","# Abstract\n# Correspondence\n# Main findings and biological context","[{\"question\":\"What roles do ENL and AF9 play in gene expression?\",\"answer\":\"ENL and AF9 function as master regulators within the transcription super elongation complex and optimize transcriptional catalytic rates at specific genomic loci.\"},{\"question\":\"What do the internal promoters drive according to the study?\",\"answer\":\"Internal promoters drive expression of YEATS-domain-devoid isoforms from MLLT3 (AF9 isoform) and from the MLLT1 locus (MLLT1 isoform), with distinct tissue activity.\"},{\"question\":\"How is YEATS-domain-devoid MLLT1 linked to cancer biomarkers?\",\"answer\":\"The YEATS-domain-devoid MLLT1 isoform shows tumor-type-specific biomarker values, with high expression in a gonadotroph pituitary tumor subtype and inverse correlation with EGFR mutation and a good-prognosis transcriptional signature in non-small cell lung cancer.\"}]","Tissue-and tumor-type-specific expression of internal-promoter-driven YEATS-domain-devoid isoforms of MLLT1 and MLLT3 | PDF",1790101979,15,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b0a44cdc1e1968030199ef676508d783.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b02c8e2a9edabac9adf3f5a0e0c98dd6.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/065b075af8aee13952d181807544a5c2.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d559fda92c2fd362884b9a9da58797ea.webp",980,1306]